null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
GYN (OVARY) CANCER
Refine Results:
All Categories
Epidemiology and Etiology (148)
Prevention and Screening (73)
Diagnosis and Staging (140)
Treatment (279)
Supportive Oncology (24)
News
BRCA1/2 Mutations Tied to Better Ovarian Cancer Survival
Elsevier Global Medical News, 2012 Jan 24, S Worcester
Bevacizumab Effective With First-Line Treatment for Ovarian Cancer
Elsevier Global Medical News, 2012 Jan 4, MA Moon
EXPERT COMMENTARY
Aflibercept Prevents Ascites Recurrence in Advanced Ovarian Cancer
Elsevier Global Medical News, 2011 Dec 21, MA Moon
Early Oophorectomy Linked to Osteoporosis, Arthritis
Elsevier Global Medical News, 2011 Dec 12, B Jancin
Ovarian Malignancy Risk Seen Doubled 15 Years After IVF
Elsevier Global Medical News, 2011 Oct 26, J Smith
More News ›
Journal Scans: Research
An Analysis of Patients With Bulky Advanced Stage Ovarian, Tubal, and Peritoneal Carcinoma Treated With Primary Debulking Surgery (PDS) During an Identical Time Period as the Randomized EORTC-NCIC Trial of PDS vs Neoadjuvant Chemotherapy (NACT)
Gynecol Oncol, 2012 Jan 1, DS Chi, et al
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
N Engl J Med, 2011 Dec 29, T Perren, et al
Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer
J Clin Oncol, 2011 Dec 27, S Kaye, et al
A High Response Rate to Liposomal Doxorubicin Is Seen Among Women With BRCA Mutations Treated for Recurrent Epithelial Ovarian Cancer
Gynecol Oncol, 2011 Dec 1, SF Adams, et al
A Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer
J Clin Oncol, 2011 Nov 7, JA Konner, et al
More Journal Scans: Research ›
Journal Scans: Review
New Biologic Agents for the Treatment of Gynecologic Cancers
Hematol Oncol Clin North Am, 2012 Feb 1, N Horowitz, et al
Evolution of Platinum Resistance in High-Grade Serous Ovarian Cancer
Lancet Oncol, 2011 Nov 1, SL Cooke, et al
Mucinous Carcinomas of the Ovary and Colorectum: Different Organ, Same Dilemma
Lancet Oncol, 2011 Oct 1, LE Kelemen, et al
American Society of Clinical Oncology 2011 Annual Meeting Update: Summary of Selected Gynecologic Cancer Abstracts
Gynecol Oncol, 2011 Aug 1, KS Tewari, et al
Neuroendocrine Tumors of the Gynecologic Tract: A Society of Gynecologic Oncology (SGO) Clinical Document
Gynecol Oncol, 2011 Jul 1, GJ Gardner, et al
More Journal Scans: Review ›
Expert Opinion
VEGF Inhibitors and Advanced Ovarian Cancer
Lancet Oncol, 2011 Oct 11, G Jayson
Ten Practice Changes I Will Make After Attending ASCO 2011
2011 Jun 28, Jeffrey Kirshner, et al
Ovarian Cancer—New Thinking on Old Regimens
2011 Feb 23, Nelson Teng
Dr. Nelson Teng: We Are Moving Towards Personalized Medicine in Ovarian Cancer
Top Stories of 2010, 2011 Jan 20, Interview by L Scott Zoeller
First Positive Trial of IV Chemotherapy in Ovarian Cancer in 13 Years
Top Stories of 2009, 2010 Jan 1
More Expert Opinion ›
Chemotherapy Regimens
Topotecan (oral) (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel I.V., cisplatin I.V. or I.P., paclitaxel I.P. (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, cisplatin (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, carboplatin (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Conference Coverage
Annual Meeting of the Society of Gynecologic Oncologists
March 14-17 2010 San Francisco, et al
Videos
Personalized Medicine: A Long Way to Go
EJC News Focus, 2011 Nov 1
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
Drug for Ovarian Cancer?
Elsevier Global Medical News, 2011 Jun 4
Collaboration Aims to Raise Women's Cancer Awareness
ASCO, 2008 May 30, Mary Ellen Schneider
Summary of Key Points
Ovaries and Fallopian Tubes
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: GYN (Ovary) Cancer
Summary information about GYN (ovary) cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
When the Smoke Clears
Experts discuss the true clinical implications of watershed developments in oncology research.
Read more ›
Commentary
Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
GYNOvary/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.